These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus. Kephart PA; Esposito AL J Antimicrob Chemother; 1988 Jan; 21(1):33-9. PubMed ID: 2833488 [TBL] [Abstract][Full Text] [Related]
5. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin]. Araujo F; Conde Estevez D; Encinas Barrios C Farm Hosp; 2012; 36(5):449-51. PubMed ID: 22484104 [No Abstract] [Full Text] [Related]
6. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with LY146032. Norden CW; Niederriter K Infection; 1988; 16(1):27. PubMed ID: 2834296 [No Abstract] [Full Text] [Related]
7. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis. Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815 [TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats. Kalteis T; Beckmann J; Schröder HJ; Handel M; Grifka J; Lehn N; Lerch K Acta Orthop; 2006 Apr; 77(2):315-9. PubMed ID: 16752296 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. Vaudaux P; Francois P; Bisognano C; Li D; Lew DP; Schrenzel J J Antimicrob Chemother; 2003 Jul; 52(1):89-95. PubMed ID: 12775678 [TBL] [Abstract][Full Text] [Related]
10. Beyond MRSA: the growing menace of hVISA and VISA. Bulchandani D; Nachnani J; Fitzsimmons C; Jost P; Brewer J South Med J; 2008 Jun; 101(6):663-4. PubMed ID: 18528225 [No Abstract] [Full Text] [Related]
11. In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis. Coudron PE; Johnston JL; Archer GL J Antimicrob Chemother; 1987 Oct; 20(4):505-11. PubMed ID: 2824426 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Xu CP; Chen Y; Sun HT; Cui Z; Yang YJ; Huang L; Yu B; Wang FZ; Yang QP; Qi Y Antimicrob Resist Infect Control; 2019; 8():182. PubMed ID: 31832182 [TBL] [Abstract][Full Text] [Related]
13. Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis. Gelfand MS; Cleveland KO South Med J; 2004 Jun; 97(6):593-7. PubMed ID: 15255429 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model. Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits. Haworth CS; Sobieski MW; Scheld WM; Park TS Antimicrob Agents Chemother; 1990 Feb; 34(2):245-51. PubMed ID: 2158276 [TBL] [Abstract][Full Text] [Related]
16. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis. Zelken J; Wanich T; Gardner M; Griffith M; Bostrom M Clin Orthop Relat Res; 2007 Sep; 462():190-4. PubMed ID: 17514008 [TBL] [Abstract][Full Text] [Related]
17. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526 [TBL] [Abstract][Full Text] [Related]